# RMDN1

## Overview
RMDN1, or regulator of microtubule dynamics 1, is a gene that encodes a protein involved in the regulation of microtubule dynamics, which are essential for various cellular processes, including cell division, intracellular transport, and structural integrity. The protein encoded by RMDN1 is categorized as a regulatory protein due to its role in modulating microtubule stability and organization. It has been implicated in several cellular pathways, including autophagy, where it interacts with Beclin 1, a key autophagy regulator (Oprea2019Autophagy). RMDN1 is also associated with metabolic processes and neurogenesis, highlighting its diverse functional roles in cellular physiology (Geng2015iTRAQbased; Liu2020Identification). Clinically, alterations in RMDN1 expression and methylation have been linked to diseases such as papillary thyroid carcinoma and uveal melanoma, suggesting its potential as a biomarker and its involvement in cancer pathogenesis (Liu2020Identification; Gelmi2023MicrophthalmiaAssociated).

## Clinical Significance
RMDN1 (regulator of microtubule dynamics 1) has been implicated in various diseases through alterations in its expression and methylation status. In papillary thyroid carcinoma (PTC), RMDN1 is significantly down-regulated and differentially methylated, suggesting that its decreased expression may be linked to abnormal DNA methylation. This alteration in methylation could potentially serve as a biomarker for PTC diagnosis, indicating a role in the disease's pathogenesis (Liu2020Identification).

In uveal melanoma (UM), RMDN1 is one of the most upregulated genes in tumors with low expression of the Microphthalmia-associated transcription factor (MITF). This suggests a potential role in the metabolic shifts observed in these tumors, although the specific clinical significance of RMDN1 mutations in UM is not detailed (Gelmi2023MicrophthalmiaAssociated).

While the studies highlight the involvement of RMDN1 in cancer, specific mutations in the gene and their direct clinical implications remain less explored. The gene's role in microtubule dynamics suggests that its dysregulation could impact cellular processes critical in cancer progression. However, further research is needed to fully elucidate its clinical significance.

## Interactions
RMDN1, also known as regulator of microtubule dynamics 1, is involved in various protein interactions that are crucial for its role in cellular processes. It has been identified as interacting with Beclin 1, a known regulator of autophagy, suggesting its potential involvement in autophagy pathways (Oprea2019Autophagy). This interaction indicates that RMDN1 may play a role in the regulation of autophagy, a cellular degradation process that is essential for maintaining cellular homeostasis.

In the context of papillary thyroid carcinoma (PTC), RMDN1 has been identified as a differentially methylated gene with significant differences in methylation status, although its specific protein interactions in this context are not detailed (Liu2020Identification). The gene set enrichment analysis suggests that RMDN1 is involved in amino acid metabolism and carbohydrate anabolism, which may imply interactions with proteins involved in these metabolic pathways (Liu2020Identification).

Additionally, in the study of newt limb regeneration, RMDN1 is associated with neurogenesis and axon guidance, indicating its involvement in microtubule dynamics and interactions with proteins related to these processes (Geng2015iTRAQbased). These interactions highlight RMDN1's role in cellular structure and function, particularly in processes involving microtubule organization and stability.


## References


[1. (Geng2015iTRAQbased) Xiao-Fang Geng, Jian-Lin Guo, Xia-Yan Zang, Jing-Yan Sun, Peng-Fei Li, Fu-Chun Zhang, and Cun-Shuan Xu. Itraq-based proteomic analysis of adaptive response in the regenerating limb of the cynops orientalis newt. The International Journal of Developmental Biology, 59(10-11–12):487–496, 2015. URL: http://dx.doi.org/10.1387/ijdb.150363cx, doi:10.1387/ijdb.150363cx. This article has 3 citations.](https://doi.org/10.1387/ijdb.150363cx)

[2. (Liu2020Identification) Yang Liu, Ting-Yu Chen, Zhi-Yan Yang, Wei Fang, Qian Wu, and Chao Zhang. Identification of hub genes in papillary thyroid carcinoma: robust rank aggregation and weighted gene co-expression network analysis. Journal of Translational Medicine, April 2020. URL: http://dx.doi.org/10.1186/s12967-020-02327-7, doi:10.1186/s12967-020-02327-7. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12967-020-02327-7)

3. (Oprea2019Autophagy) Autophagy dark genes: Can we find them with machine learning?. This article has 4 citations.

[4. (Gelmi2023MicrophthalmiaAssociated) Maria Chiara Gelmi, Robert M. Verdijk, Laurien E. Houtzagers, Pieter A. van der Velden, Wilma G. M. Kroes, Gregorius P. M. Luyten, T. H. Khanh Vu, and Martine J. Jager. Microphthalmia-associated transcription factor: a differentiation marker in uveal melanoma. International Journal of Molecular Sciences, 24(10):8861, May 2023. URL: http://dx.doi.org/10.3390/ijms24108861, doi:10.3390/ijms24108861. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24108861)